Back to Search Start Over

Optimizing therapy to prevent avoidable hospital admissions in multimorbid older adults (OPERAM)

Authors :
Dimitris Mavridis
Ingeborg Wilting
Marco Spruit
Sophie Marien
Nathalie Schwab
Matthias Schwenkglenks
Manuel R. Blum
Christine Baumgartner
Drahomir Aujesky
Marie C. Roumet
Bastiaan T.G.M. Sallevelt
Carole E. Aubert
Denis O'Mahony
Maria de Montmollin
Olivia Dalleur
Anne Eichenberger
Zhengru Shen
Anne Fournier
Arend-Jan Meinders
Katharina Tabea Jungo
Oliver Baretella
Laura Gleeson
Stephen Byrne
Michiel Meulendijk
Erin K. Crowley
Corlina Johanna Alida Huibers
Paul A. F. Jansen
Sven Trelle
Stefanie Thevelin
Lisa Bretagne
Martin Feller
Emma Jennings
A. Clara Drenth-van Maanen
Marvin J Roos
Nicolas Rodondi
Elisavet Moutzouri
Shanthi Beglinger
Benoît Boland
Seraina Netzer
Cian O'Mahony
Kevin D. Murphy
Anne Spinewine
Luise Adam
Ariane Mouzon
Wilma Knol
UCL - SSS/LDRI - Louvain Drug Research Institute
UCL - SSS/IRSS - Institut de recherche santé et société
UCL - (MGD) Département de pharmacie
UCL - (SLuc) Département de pharmacie
UCL - (SLuc) Service de gériatrie
Source :
BMJ-BRITISH MEDICAL JOURNAL, Blum, Manuel R; Sallevelt, Bastiaan T G M; Spinewine, Anne; O'Mahony, Denis; Moutzouri, Elisavet; Feller, Martin; Baumgartner, Christine; Roumet, Marie; Jungo, Katharina Tabea; Schwab, Nathalie; Bretagne, Lisa; Beglinger, Shanthi; Aubert, Carole E; Wilting, Ingeborg; Thevelin, Stefanie; Murphy, Kevin; Huibers, Corlina J A; Drenth-van Maanen, A Clara; Boland, Benoit; Crowley, Erin; ... (2021). Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial. BMJ, 374, n1585. BMJ Publishing Group 10.1136/bmj.n1585 , BMJ, Vol. ;374, p. n1585 [1-13] (2021), BMJ, 374. BMJ PUBLISHING GROUP, BRITISH MEDICAL JOURNAL, 374. BMJ PUBLISHING GROUP
Publication Year :
2021
Publisher :
BMJ PUBLISHING GROUP, 2021.

Abstract

Objective To examine the effect of optimising drug treatment on drug related hospital admissions in older adults with multimorbidity and polypharmacy admitted to hospital. Design Cluster randomised controlled trial. Setting 110 clusters of inpatient wards within university based hospitals in four European countries (Switzerland, Netherlands, Belgium, and Republic of Ireland) defined by attending hospital doctors. Participants 2008 older adults (≥70 years) with multimorbidity (≥3 chronic conditions) and polypharmacy (≥5 drugs used long term). Intervention Clinical staff clusters were randomised to usual care or a structured pharmacotherapy optimisation intervention performed at the individual level jointly by a doctor and a pharmacist, with the support of a clinical decision software system deploying the screening tool of older person’s prescriptions and screening tool to alert to the right treatment (STOPP/START) criteria to identify potentially inappropriate prescribing. Main outcome measure Primary outcome was first drug related hospital admission within 12 months. Results 2008 older adults (median nine drugs) were randomised and enrolled in 54 intervention clusters (963 participants) and 56 control clusters (1045 participants) receiving usual care. In the intervention arm, 86.1% of participants (n=789) had inappropriate prescribing, with a mean of 2.75 (SD 2.24) STOPP/START recommendations for each participant. 62.2% (n=491) had ≥1 recommendation successfully implemented at two months, predominantly discontinuation of potentially inappropriate drugs. In the intervention group, 211 participants (21.9%) experienced a first drug related hospital admission compared with 234 (22.4%) in the control group. In the intention-to-treat analysis censored for death as competing event (n=375, 18.7%), the hazard ratio for first drug related hospital admission was 0.95 (95% confidence interval 0.77 to 1.17). In the per protocol analysis, the hazard ratio for a drug related hospital admission was 0.91 (0.69 to 1.19). The hazard ratio for first fall was 0.96 (0.79 to 1.15; 237 v 263 first falls) and for death was 0.90 (0.71 to 1.13; 172 v 203 deaths). Conclusions Inappropriate prescribing was common in older adults with multimorbidity and polypharmacy admitted to hospital and was reduced through an intervention to optimise pharmacotherapy, but without effect on drug related hospital admissions. Additional efforts are needed to identify pharmacotherapy optimisation interventions that reduce inappropriate prescribing and improve patient outcomes. Trial registration ClinicalTrials.gov NCT02986425 .

Details

Language :
English
Database :
OpenAIRE
Journal :
BMJ-BRITISH MEDICAL JOURNAL, Blum, Manuel R; Sallevelt, Bastiaan T G M; Spinewine, Anne; O&#39;Mahony, Denis; Moutzouri, Elisavet; Feller, Martin; Baumgartner, Christine; Roumet, Marie; Jungo, Katharina Tabea; Schwab, Nathalie; Bretagne, Lisa; Beglinger, Shanthi; Aubert, Carole E; Wilting, Ingeborg; Thevelin, Stefanie; Murphy, Kevin; Huibers, Corlina J A; Drenth-van Maanen, A Clara; Boland, Benoit; Crowley, Erin; ... (2021). Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial. BMJ, 374, n1585. BMJ Publishing Group 10.1136/bmj.n1585 <http://dx.doi.org/10.1136/bmj.n1585>, BMJ, Vol. ;374, p. n1585 [1-13] (2021), BMJ, 374. BMJ PUBLISHING GROUP, BRITISH MEDICAL JOURNAL, 374. BMJ PUBLISHING GROUP
Accession number :
edsair.doi.dedup.....a4d5d1aa9cfc8ea5f8c5db0832397d95
Full Text :
https://doi.org/10.1136/bmj.n1585